OncoNano has substantial experience with multiple payloads:
- Bi-specific and monoclonal antibodies
- Cytokines
- Fusion proteins
- Small molecules
Please contact us if there are any payloads in your pipeline that can benefit from:
- Reduced systemic toxicity
- Improved therapeutic index
- Direct payloads delivery and subsequent conditional release at the TME